Peter Zhang
Head of Biostatistics Department @ Otsuka Holdings
Peter Zhang is a startup investor at Otsuka Holdings. Peter Zhang, Ph.D. has over 25 years of experience in the Pharmaceutical Industry with a diverse experience in Drug Development including preclinical, Phase I/II/III/IV and also life cycle management (LCM). He has also supported more than 15 NDAs/sNDAs/MAAs/NDS/PMDA. and several INDs across various therapeuticareas including CNS (Alzheimer’s disease, MDD, Schizophrenia, Bipolar, ADHD), Cardiovascular (BP, ACS, Intermittent Claudication), Respiratory disease (Asthma, COPD, RDS), Gastrointestinal Disease (Ulcerative Colitis, IBD, Crohn’s Disease), Anti-Infection (UTI, LRTI, MDR-TB), Oncology (Advance colorectal cancer, MDS, AML, Cancer Pain, and CML), and Ophthalmology (Dry eye, Dry AMD). The hallmark of his career is his successful leadership in biostatistics, programming, quantitative analytics, statistical reporting, global drug development, and global medical affairs/HEOR, and CMC & QC at several pharmaceutical companies in the United States such as Procter & Gamble Pharmaceuticals, Novartis Pharmaceuticals, Forest Laboratories (now Allergan), and Otsuka Pharmaceutical Development and Commercialization, Inc. Peter is currently Head of Biostatistics Department at Otsuka Pharmaceuticals (US) that focusses on collecting, integrating, analyzing, interpreting and providing insight from the many data sources that exist across various functions.Peter has published over 110 abstracts and manuscripts in various international statistical and medical Journals. He has also written several book chapters. His research interest areas are the nonparametric Bayesian method, meta-analysis/network meta-analysis, missing data, enrichment clinical trial design, and SPCD/re-randomization design. He graduated with a Ph.D. in Statistics from Purdue University, an M.S. in Computing Statistics from Chinese Academy of Sciences, and a B.S. in Mathematics from Peking University.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
About Otsuka Holdings
Otsuka Pharmaceutical was established in Tokushima Prefecture, Japan in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original: pharmaceutical and nutraceutical products based on our corporate philosophy “Otsuka-people creating newproducts for better health worldwide”. Analogous to riding on a bicycle, we drive on two wheels.
Otsuka Holdings Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Roch Doliveux
CEO
|
|||
|
Busaburo Otsuka
Founder
|
|||
Debbie Profit
Vice President, OIT
|
|||
Lisa Strouss
Director of Field Medical Digital Health
|
|||
|
Peter Zhang
Head of Biostatistics Department
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Peter Zhang?
Public channels for Peter Zhang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
